Revel, France

Jean-Pierre Valentin

This inventor holds 2 USPTO granted patents. Top assignee: Pierre Fabre Medicament. Active years: 1998-2000.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Catanet-Tolosan, FR (1998)
  • Revel, FR (2000)

Company Filing History:


Years Active: 1998-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Jean-Pierre Valentin

Introduction

Jean-Pierre Valentin is a notable inventor based in Revel, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds for treating cardiovascular conditions. With a total of 2 patents, his work has garnered attention in the pharmaceutical industry.

Latest Patents

Valentin's latest patents include innovative solutions such as "Heterocyclic compounds for treating myocardial ischemia" and "Aromatic ethers derived from indoles which are useful as medicaments." These inventions reflect his commitment to advancing medical treatments and improving patient outcomes.

Career Highlights

Jean-Pierre Valentin is currently employed at Pierre Fabre Medicament, a prominent company in the pharmaceutical sector. His role involves research and development, where he applies his expertise to create effective medicinal products. His contributions have been instrumental in the company's success in bringing new therapies to market.

Collaborations

Throughout his career, Valentin has collaborated with esteemed colleagues, including Gareth W John and Jean-Pierre Rieu. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.

Conclusion

Jean-Pierre Valentin's work exemplifies the impact of dedicated inventors in the field of medicine. His patents and collaborations highlight the importance of innovation in developing new treatments for critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…